Introducing Altasciences Company Inc
ALTASCIENCES, currently comprises of Simbec Research Ltd (UK) and Algorithme Pharma (Canada). Both companies will continue to provide comprehensive worldwide early stage clinical drug development services from Bioequivalence to Phase I/ IIa, including the necessary support services in this critical stage of drug development.
While each of these units will maintain its identity, with each having brand recognition, they will be linked together by a common focus on excellence in customer service, operating under the ALTASCIENCES umbrella name. ALTASCIENCES is the vehicle to support the strategic growth and business diversification planned for the future.
Our goal is to provide the best quality early stage clinical development services to an international customer base of pharmaceutical, biotech and generic companies with a focus on customer service. We will achieve this by continuously looking for ways to improve our customer relationships and range of services and by creating an environment that provides value for our customers, respect for our volunteers, returns for our shareholders and growth for our employees.
Simbec at a Glance:
After over 35 years in business, Simbec Research has conducted over 1500 early phase clinical studies, created, planned and managed within a wide range of therapeutic areas. Simbec is dedicated to quality and Simbec’s expertise in the conduct of experimental human pharmacology, particularly Phase I First in Human and Phase IIa proof of concept clinical trials is world-renowned.
Founded in 1976 with a small team of researchers from the UK National Health Service, Simbec Research is now one of Europe’s leading contract research organisations specialising in early clinical research services for the international pharmaceutical
Algorithme Pharma at a Glance:
Founded in 1992 with a small team of researchers from the pharmacology department of the Université de Montréal, Algorithme Pharma is the largest privately held Québec owned organisation specialising in research services for the international pharmaceutical industry.